USANA Health Sciences, Inc.
USNA
$23.83
$0.090.38%
NYSE
| 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -7.22% | -7.10% | -7.67% | -7.56% | -7.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.22% | -7.10% | -7.67% | -7.56% | -7.77% |
| Cost of Revenue | -8.76% | -8.75% | -8.97% | -10.36% | -8.87% |
| Gross Profit | -6.86% | -6.70% | -7.36% | -6.88% | -7.51% |
| SG&A Expenses | -3.73% | -6.26% | -6.61% | -6.36% | -6.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.80% | -6.80% | -7.12% | -7.24% | -7.08% |
| Operating Income | -28.74% | -9.92% | -12.54% | -10.35% | -13.51% |
| Income Before Tax | -25.48% | -6.20% | -6.79% | -2.67% | -5.68% |
| Income Tax Expenses | -11.31% | -1.64% | 3.79% | 1.43% | -1.54% |
| Earnings from Continuing Operations | -34.06% | -9.15% | -13.12% | -5.09% | -8.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -34.11% | -9.15% | -13.12% | -5.09% | -8.02% |
| EBIT | -28.74% | -9.92% | -12.54% | -10.35% | -13.51% |
| EBITDA | -23.55% | -8.33% | -11.14% | -9.88% | -12.59% |
| EPS Basic | -33.55% | -8.57% | -12.75% | -5.11% | -8.07% |
| Normalized Basic EPS | -24.89% | -5.58% | -6.38% | -2.68% | -5.72% |
| EPS Diluted | -33.79% | -8.50% | -12.70% | -5.12% | -7.90% |
| Normalized Diluted EPS | -24.90% | -5.52% | -6.54% | -2.98% | -5.78% |
| Average Basic Shares Outstanding | -0.87% | -0.69% | -0.44% | 0.01% | 0.07% |
| Average Diluted Shares Outstanding | -0.95% | -0.77% | -0.24% | 0.35% | 0.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |